Table 3 Descriptive statistics in women and men participants (1) for the RST-PQ, ECQ, STAI-Y1; (2) for numerical pain and unpleasantness scores: (i) of the Self in the Control (SC-NPS, and SC-NUS), Placebo (SP-NPS, and SP-NUS) treatments and Control minus Placebo difference scores (S_NPDS and S_NUDS); (j) of the Other in the Control (OC-NPS, and OC-NUS), Placebo (OP-NPS, and OP-NUS) treatments and Control minus Placebo difference scores (O_NPDS and O_NUDS).
Variable | Women (N = 32) | Men (N = 30) | Gender | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Min | Max | Mean | SD | Min | Max | t(60) | p(FDR) | |
BAS-TOT | 94.1 | 12.9 | 71 | 125 | 89.3 | 11.1 | 67 | 113 | 1.58 | 0.421 |
BAS-GDP | 21.9 | 3.9 | 12 | 28 | 21.4 | 2.9 | 16 | 28 | 0.58 | 0.736 |
BAS-RI | 20.6 | 4.6 | 11 | 28 | 20.2 | 4.1 | 12 | 28 | 0.3 | 0.831 |
BAS-RR | 31.0 | 4.9 | 19 | 39 | 29.3 | 4.5 | 20 | 39 | 1.42 | 0.421 |
BAS-I | 20.7 | 5.1 | 3 | 32 | 18.4 | 4.3 | 10 | 25 | 1.94 | 0.368 |
BIS | 61.3 | 12.6 | 42 | 85 | 53.5 | 11.8 | 29 | 80 | 2.52 | 0.183 |
FFFS | 28.9 | 4.2 | 23 | 37 | 22.9 | 6.4 | 12 | 37 | 4.42 | 0.003 |
CE | 36.3 | 3.6 | 27 | 42 | 36.6 | 4.5 | 24 | 44 | − 0.34 | 0.831 |
AE | 49.6 | 9.1 | 32 | 64 | 47.3 | 7.7 | 24 | 60 | 1.1 | 0.471 |
ED | 30.2 | 3.2 | 23 | 36 | 29.0 | 3.4 | 20 | 36 | 1.4 | 0.421 |
TEA | 37.5 | 5.3 | 28 | 56 | 35.8 | 3.6 | 29 | 44 | 1.47 | 0.421 |
CTE | 87.4 | 14.0 | 29 | 106 | 83.0 | 12.7 | 36 | 103 | 1.31 | 0.421 |
STAI-Y1 (C) | 36.8 | 9.8 | 22 | 57 | 33.9 | 9.3 | 20 | 67 | 1.21 | 0.461 |
STAI-Y1 (P) | 36.7 | 11.3 | 22 | 72 | 33.6 | 10.0 | 20 | 59 | 1.15 | 0.471 |
SC-NPS | 5.41 | 1.11 | 1.54 | 6.71 | 5.00 | 1.23 | 1.21 | 6.75 | 1.37 | 0.421 |
SP-NPS | 4.99 | 1.02 | 2.63 | 6.79 | 4.32 | 1.20 | 1.46 | 6.25 | 2.37 | 0.042 |
S_NPDS | 0.42 | 0.96 | − 3.09 | 2.04 | 0.68 | 0.99 | − 0.83 | 3.29 | − 1.07 | 0.471 |
SC-NUS | 5.15 | 1.25 | 1.21 | 6.75 | 4.65 | 1.47 | 1.04 | 6.67 | 1.46 | 0.421 |
SP-NUS | 4.74 | 1.16 | 2.25 | 6.29 | 4.29 | 1.47 | 1.00 | 6.42 | 1.36 | 0.421 |
S_NUDS | 0.41 | 1.22 | − 3.12 | 2.30 | 0.36 | 0.72 | − 1.17 | 1.62 | 0.19 | 0.880 |
OC-NPS | 4.97 | 1.06 | 2.33 | 6.50 | 4.83 | 1.20 | 2.08 | 6.50 | 0.49 | 0.736 |
OP-NPS | 4.88 | 1.21 | 2.25 | 6.50 | 4.88 | 1.29 | 1.17 | 6.54 | 0.00 | 0.997 |
O_NPDS | 0.09 | 1.06 | − 2.71 | 2.46 | − 0.05 | 1.04 | − 4.05 | 1.84 | 0.54 | 0.736 |
OC-NUS | 4.97 | 1.18 | 2.08 | 6.50 | 4.80 | 1.46 | 1.00 | 6.83 | 0.8 | 0.657 |
OP-NUS | 4.63 | 1.25 | 1.83 | 6.83 | 4.46 | 1.33 | 2.25 | 6.50 | 0.51 | 0.736 |
O_NUDS | 0.34 | 0.68 | − 0.79 | 2.09 | 0.34 | 0.64 | − 1.25 | 1.46 | 0.6 | 0.736 |